Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1410

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1350 to $1410.